Armodafinil 250 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FGRYP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,673
Award facts
- Contract value 100% obligated
- $1,672.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems through DLA's Medical Supply Chain. This delivery order for Armodafinil, a wakefulness-promoting medication commonly used in military and federal healthcare settings, exemplifies the company's role in fulfilling federal medical supply needs across multiple therapeutic domains. The competitive, non-set-aside award reflects AmerisourceBergen's established capability to meet federal procurement requirements and maintain its position as a primary pharmaceutical vendor for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FGRYP?
SPE2DB26FGRYP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FGRYP worth?
The government has obligated $1,673 on SPE2DB26FGRYP.
Is contract SPE2DB26FGRYP an order under another contract?
Yes. SPE2DB26FGRYP is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB26FGRYP competed?
The extent of competition for SPE2DB26FGRYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award